Risankizumab
MedicationWikipedia
32
MENTIONS
13
EPISODES
12
PODCASTS
Search complete. 32 mentions across 13 episodes found for "Risankizumab".
Sep 17, 2026
speaker_2UNKNOWN
Ask your doctor about SKYRIZI, the number one dermatologist-prescribed biologic in psoriasis.
speaker_2UNKNOWN
Visit skyrizi.com or call 1-866-SKYRIZI to learn more.
speaker_2UNKNOWN
[upbeat music]
speaker_26ADVERTISER
10 hours on my feet, traffic, noise, everybody needing something from me.
18 MINS LATER
speaker_2UNKNOWN
Now there's nothing on my skin thanks to SKYRIZI, and that means everything.
speaker_2UNKNOWN
Ask your doctor about SKYRIZI, the number one dermatologist-prescribed biologic in psoriasis.
speaker_2UNKNOWN
Visit skyrizi.com or call 1-866-SKYRIZI to learn more.
speaker_26ADVERTISER
10 hours on my feet, traffic, noise, everybody needing something from me.
Christopher ChangHOST
... uh, ads on TV.
Jackie O'BrienHOST
Skyrizi
Christopher ChangHOST
...
Christopher ChangHOST
Skyrizi, and, and all these things-
Jackie O'BrienHOST
[laughs] Every day, all day
Christopher ChangHOST
... that are like, yeah, all these things.
KippyHOST
I'm like, "That sounds like a, like a teenage girl's name.
KippyHOST
Skyri- "Hi, I'm Skyrizi." Like, [laughs]
DanHOST
Oh, no.
KippyHOST
Um, the other one is Tip- I'm Tapezza.
Brian GreenHOST
But it's some of the dumbest shit you see.
Krissy HoadleyHOST
Skyrizi?
Brian GreenHOST
Yeah, Skyrizi.
Krissy HoadleyHOST
[laughs]
Brian GreenHOST
Rizvezzi.
Mike DHOST
Yeah.
KelseyHOST
And it kind of reminds me of the like Skyrizi commercial.
KelseyHOST
You know which I'm talking about?
Mike DHOST
Oh, yeah, yeah.
Matt LiebHOST
Yes
Kath BarbadoroGUEST
... uh, Skyrizi is the one we always reference on my podcast.
Kath BarbadoroGUEST
They all have-
Matt LiebHOST
Sky- [laughs] Skyrizi is my-
Kath BarbadoroGUEST
... insane names
Matt LiebHOST
... favorite.
Kath BarbadoroGUEST
"How do we do this?"
Vince ManciniHOST
[laughs] Yeah.
Ben PetersNARRATOR
Group revenues grew 10% year on year, led by another strong quarter from Immunology, where revenues increased 15%.
Ben PetersNARRATOR
Skyrizi and Rynvok grew 24% and 25% respectively, more than offsetting the decline in Humira, and providing further evidence that AbbVie has successfully transitioned its immunology franchise beyond its former blockbuster.
Ben PetersNARRATOR
There remains significant runway for both drugs as they continue to gain share across multiple indications.
Ben PetersNARRATOR
AbbVie is also reinvesting from a position of strength to extend its immunology leadership into the next decade.
Ben PetersNARRATOR
Group revenues grew 10% year on year, led by another strong quarter from Immunology, where revenues increased 15%.
Ben PetersNARRATOR
Skyrizi and Rynvok grew 24% and 25% respectively, more than offsetting the decline in Humira, and providing further evidence that AbbVie has successfully transitioned its immunology franchise beyond its former blockbuster.
Ben PetersNARRATOR
There remains significant runway for both drugs as they continue to gain share across multiple indications.
Ben PetersNARRATOR
AbbVie is also reinvesting from a position of strength to extend its immunology leadership into the next decade.
Dave VanVickleHOST
All right.
Mike GormleyHOST
And he said, "And they all come in thinking they have medical degrees 'cause they're like, 'Well, now I need Skyrizi.
Mike GormleyHOST
Now I need...'"
Stacy GilsonGUEST
[laughs]
Pradip MundrayHOST
I, I don't use these terms, I use the drug names.
Pradip MundrayHOST
But anyway, the, the, the new drugs, cosielkimab, mirikizumab, and risankizumab, so this applies, this rule applies to them as well?
Mette JulsgaardGUEST
well?No, definitely not.
Mette JulsgaardGUEST
So the, the new anti-IL twenty-three inhibitors, risankizumab, mirikizumab, guselkumab, they are all biologics, so large immunoglobulins which doesn't pass placenta during the first trimester.
Mette JulsgaardGUEST
They start passing actively from around gestation week, uh, fifteen, sixteen, and throughout pregnancy exponential increase during the third, uh, trimester.
Mette JulsgaardGUEST
Just like we know for infliximab, adalimumab, ustekinumab, and vedolizumab, they are all biologics, and of course we have so far limited, uh, safety data with these newer biologics, but I am completely at ease by using them in pregnancy because we have such a great knowledge regarding the other biologics which we have used, like infliximab have been in use since around year two thousand, and we have really seen an exponential increase in the use of TNF alpha inhibitors like the biologics since twenty ten and up until now, and we have a lot of safety data regarding its, its use in pregnancy.
8 MINS LATER
Mette JulsgaardGUEST
I rarely have experienced patients falling pregnant on methotrexate, then referral to the obstetric department, extra scan, discontinue the treatment, initiate another type of treatment, another, like a biologic, which is perfectly safe, uh, during pregnancy.
Mette JulsgaardGUEST
So, and that sort of leads on to the biologics.
3 more episodes mention Risankizumab.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.